Impact of disrupted botulinum toxin therapy in movement disorders due to COVID-19 pandemic Neeraja K, Surisetti BK, Mol N, Prasad S, Holla VV, Kamble N, Mahale R, Pal PK, Yadav R,


Users Online: 897	Home \| About the Journal \| Instructions \| Current Issue \| Back Issues \| Login



LETTER TO THE EDITOR

Ahead of print publication

Impact of disrupted botulinum toxin therapy in movement disorders due to COVID-19 pandemic

Koti Neeraja¹, Bharath Kumar Surisetti¹, Nisha Mol¹, Shweta Prasad², Vikram Venkappayya Holla¹, Nitish Kamble¹, Rohan Mahale¹, Pramod Kumar Pal¹, Ravi Yadav¹
¹ Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India
² Department of Neurology; Department of Clinical Neurosciences, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India

Date of Submission	09-Jun-2020
Date of Acceptance	09-Jun-2020

Correspondence Address:
Ravi Yadav,
Professor, Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Hosur Road, Bengaluru - 560 029, Karnataka
India

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/aian.AIAN_573_20

How to cite this URL:
Neeraja K, Surisetti BK, Mol N, Prasad S, Holla VV, Kamble N, Mahale R, Pal PK, Yadav R. Impact of disrupted botulinum toxin therapy in movement disorders due to COVID-19 pandemic. Ann Indian Acad Neurol [Epub ahead of print] [cited 2021 Jan 20]. Available from: https://www.annalsofian.org/preprintarticle.asp?id=294286

Ahead Of Print

     Search Pubmed for

    -  Neeraja K
    -  Surisetti BK
    -  Mol N
    -  Prasad S
    -  Holla VV
    -  Kamble N
    -  Mahale R
    -  Pal PK
    -  Yadav R

Article in PDF

Article Access Statistics

Viewed	249

PDF Downloaded	10